References
- Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: disability and economic costs. Arch Intern Med 1999;159:813–8
- Silberstein SD. Treatment of the migraine attack. Curr Opin Neurol 1994;7:258–63
- Silberstein SD. Migraine symptoms: results of a survey of selfreported migraineurs. Headache 1995;35:387–96
- Worthington I. Delivery systems for acute migraine medications. Can Fam Physician 2001;47:322–9
- MacGregor EA, Brandes J, Eikermann A. Migraine prevalence and treatment patterns: the Global Migraine and Zolmitriptan Evaluation Survey. Headache 2003;43(1):19–26
- Lipton RB, Hamelsky SW Dayno JM. What do patients with migraine want from acute migraine treatment? Headache 2002;42(Suppl)1:3–9
- Rapoport AM, Ramadan NM, Adelman JU, et al. Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group. Neurology 1997;49: 1210–8
- Gallagher RM, Dennish G, Spierings EL, Chitra R. A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine. Headache 2000;40:119–28
- Solomon GD, Cady RK, Klapper JA, Earl NL, Saper JR, Ramadan NM, on behalf of the 042 Clinical Trial Study Group. Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. Neurology 1997;49:1219–25
- Geraud G, Compagnon A, Rossi A. Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: a double-blind, randomised, three-attack study. Eur Neurol 2002;47:88–98
- Dowson AJ, MacGregor EA, Purdy RA, Becker WJ, Green J, Levy SL. Zolmitriptan melting tablet is effective in the acute treatment of migraine. Cephalalgia 2002;22:101–6
- International 311C90 Long-term Study Group. The long-term tolerability and efficacy of oral zolmitriptan (Zomig, 311C90) in the acute treatment of migraine: an international study. Headache 1998;38: 173–83
- Cady RK, Sheftell F, Lipton RB, et al. Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials. Clin Ther 2000;22:1035–48
- Pascual J, Cabarrocas X. Within-patient early versus delayed treatment of migraine attacks with almotriptan: the sooner, the better. Headache 2002;42:28–31
- World Medical Organization. Declaration of Helsinki. Br Med J 1996;313:1448–9
- Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(Suppl 7):1–96
- Klapper J, Lucas C, Røsjø Ø, Charlesworth B, on behalf of the ZODIAC study group. Benefits of treating highly disabled migraine patients with zolmitriptan while pain is mild. Cephalalgia 2004;24(11):918–24
- Burstein R. Triptan therapy can abort migraine attacks if given before the establishment or in the absence of cutaneous allodynia and central sensitization: clinical and preclinical evidence. Headache 2002;42(5):390–1